Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Organisation › Details

SR Pharma plc (AIM: SPA.L)

SR Pharma plc is a European biopharmaceutical company, listed on AIM. The Company has two operating subsidiaries Atugen AG (www.atugen.com) based in Berlin, Germany and Stanford Rook Ltd based in London, UK. SR Pharma is a leader in RNAi therapeutics, which is a Nobel Prize winning technology that ”silences” genes linked to the onset of disease. The Company has developed novel, chemically modified proprietary siRNA molecules ("AtuRNAi"), which have a number of advantages over conventional siRNA molecules including enhanced stability against nuclease degradation. In addition, the Company has developed a proprietary delivery system ("AtuPLEX"), which increases bioavailability, circulation times and functional intracellular uptake of siRNA molecules. *

 

Period Start 1992-01-01 established
Period End 2007-04-26 renamed
  Group Silence Therapeutics (Group)
  Today Silence Therapeutics plc (Nasdaq: SLN)
  Successor Silence Therapeutics plc (Nasdaq: SLN)
Product Industry RNAi drug (RNAi therapeutic)
     
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 103 New Oxford Street, Centre Point, 26th Floor
  City WC1A 1DD London
  Tel +44-20-7307-1620
    Address record changed: 2009-02-27
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Silence Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top